title: Axonal regeneration, but not myelination, is partially dependent on local cholesterol reutilization in regenerating nerve.
abstract: A recycling pathway in peripheral nerve permits cholesterol from degenerating myelin to be salvaged by macrophages and resupplied to myelinating Schwann cells by locally produced lipoproteins. A similar reutilization of cholesterol by regenerating axons has been proposed but not demonstrated. Neurites in culture, however, do take up cholesterol and cholesterol-containing lipoproteins, where these molecules are found to promote neurite extension. To test the requirement for cholesterol reutilization in axon regeneration and myelination, we examined 2 models of blocked intracellular cholesterol transport: 1) bone marrow transplants from Niemann-Pick C mice into wild-type recipient mice, and 2) imipramine treatment. Following nerve crush in these models, we found that unusually large, debris-filled macrophages appeared and persisted for many weeks. A morphometric analysis of regenerating nerves revealed that myelination proceeded at a normal rate (normal g-ratios), but that axon growth was retarded (decreased fiber numbers and diameters) in these animals. Cholesterol synthesis was elevated in these nerves, indicating that Schwann cells compensated for the decreased exogenous supply of cholesterol by up-regulating de novo synthesis to support myelination. These data indicate that Schwann cells are not dependent on cholesterol reutilization to support myelination, but that optimal axonal regeneration is dependent on a local supply of cholesterol.
authors.affiliation: Neuroscience Center, Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, 27599, USA.
authors.forename: J F
authors.initials: JF
authors.lastname: Goodrum
authors.forename: J C
authors.initials: JC
authors.lastname: Brown
authors.forename: K A
authors.initials: KA
authors.lastname: Fowler
authors.forename: T W
authors.initials: TW
authors.lastname: Bouldin
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000378:metabolism*; D001854:Bone Marrow Cells / Q000473:pathology; D016026:Bone Marrow Transplantation; D002784:Cholesterol / Q000378:metabolism*; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology; D008264:Macrophages / Q000473:pathology; D008297:Male; D051379:Mice; D009186:Myelin Sheath / Q000502:physiology*; D009409:Nerve Crush; D009416:Nerve Regeneration / Q000502:physiology*; D009542:Niemann-Pick Diseases / Q000235:genetics / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012583:Schwann Cells / Q000378:metabolism*; D012584:Sciatic Nerve / Q000502:physiology*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D007099:Imipramine